Nadav Reuben
CEO & Co-Founder
[one line: background, previous company, years in medical devices]
Narix Medical Innovations
Reshaping the way we heal, actively.
A bioactive microneedle hydrogel pad and a connected app, working together on the wound and on the data it produces.
Most wound care protects the wound.
NarixPad works with it.
Hard-to-heal wounds need more than passive care
Millions of patients live with wounds caused by trauma, burns, pressure injuries, surgery and diabetes. Most wound-care products protect the wound but do not actively shape how it heals.
Patients and medical teams need something effective, comfortable and easy to use, that also produces a record of what actually happened during healing.
An active wound-healing platform
NarixPad delivers bioactive, mineral-based components directly to the wound environment while supporting the conditions for tissue regeneration. The Nevo App turns each dressing change into structured data.
NARIXPAD
Bioactive microneedle hydrogel
A mineral-based hydrogel pad with a microneedle array, designed to deliver its bioactive components into the wound bed rather than sitting on top of it. Localized, non-drug support with comfort and protection built in.
NEVO APP
Connected wound tracking
Photo-based wound-progress tracking, structured documentation and a clinical dashboard with AI support, so treatment and insight stay connected across the whole healing journey.
What it does
Bioactive microneedle hydrogel
Localized, non-drug support
Comfort and wound protection
Digital wound-progress tracking
Clinical dashboard with AI support
Connects treatment and insight
A large market moving toward active care
TAM
Global wound care
$30.48B
by 2030, from $20.97B in 2024. 6.5% CAGR.
SAM
Advanced wound care
$27.5B
by 2034, from $15.6B in 2024. 5.9% CAGR.
SOM
0.01% of SAM
$156M
five years from market approval.
The people building Narix
A small team pairing product and commercial experience with the clinical and regulatory work a wound-care device demands.
Ariela Disenhouse Levi
BD & Co-Founder
[one line: background, previous company, what she owns here]
+
Clinical advisor
Open
A wound-care physician who can speak to the clinical need and the trial design.
+
Regulatory lead
Open
Someone who has taken a class II device through CE or FDA before.
Talk to us about Narix
We are currently [stage] and speaking with investors, clinical partners and grant programs. Ask for the full one-pager or the deck.